I am a virologist with a special interest in the study of the fundamental mechanisms of virus multiplication and their links to human health. I have a dual medical and scientific background that allows me to address both the fundamental aspects of virology and medical issues. My research focuses on the study of the replication mechanisms of the respiratory syncytial virus (RSV). My team is particularly focused on the understanding of viral factories, membrane-free viral-induced compartments, which host the central steps of RSV multiplication; and on the study of the late phases of viral multiplication (from the transport of new viral genomes to the release of virions). I joined the Pasteur Institute in January 2023 with my team to continue our work on RSV and to bring my medical skills and expertise on RSV to the National Reference Center for Respiratory Infections (including influenza).

RAMEIX épouse WELTI Marie-Anne

RPPS : 10100139756

Research ID – ORCID 0000-0002-5901-3856

Present position

PU-PH : Professor (Paris Saclay – UVSQ), with Attending Physician clinical duties (Hôpital Ambroise Paré APHP, Pr Gault).

Team-Leader in INSERM – Paris-Saclay Versailles St-Quentin University- U1173 and Pasteur Institute (M3P)

Medical coordinator in CNR des infections respiratoires, Pasteur Institute, Paris

Education

HDR “habilitation to supervise research » (2018), Versailles St-Quentin University, France

PhD, Microbiology-Virology, Paris Diderot University, France (2008)

MD– Medical Biology, Paris Descartes University, France (2010)

National Attending physician habilitation (Clinical microbiology), France (2015)

Master 2, Microbiology option Virology, Paris Diderot University, France (2005)

Studies of Biology at Ecole Normale Supérieure Ulm, France (1996-2000)

Medical studies – Paris Descartes University (Paris 5) – Necker Enfants Malades, France (1994-2000)

Previous positions

2000-04                Residency           Assistance Publique des Hôpitaux de Paris (AP-HP)

2004-05                Master 2 Institut Pasteur, GMVR unit (Master 2 Scholarship from ARS)

2005-08                PhD Institut Pasteur, GMVR unit (Scholarship from CMIT-Institut Pasteur)

2008-10                Residency           Assistance Publique des Hôpitaux de Paris

2010-15                AHU– Post-Graduate Clinical Fellow        Versailles Saint-Quentin University/Ambroise Paré Hospital APHP

2015-16                PHU– Post-Graduate Clinical Fellow        Versailles Saint-Quentin University/Ambroise Paré Hospital APHP

2016-20                MCU-PH, Associate Professor, with Attending Physician clinical duties    Paris-Saclay-Versailles Saint-Quentin University/Ambroise Paré Hospital AP-HP

Teaching

Paris-Saclay, Versailles St Quentin University, DFGSM3 (medical L3) around 15h/year

Paris-Saclay, Versailles St Quentin University, Master 2 A2I 4h/year

Paris-Saclay, Versailles St Quentin University; in charge of a teaching unit of the M2 A2I UVSQ since 2016

Paris Cité University, Pasteur Insitute, Master 2 2h/year

Paris Cité University, Master 1 2h/year

Responsabilities

Member (vice-director) of the Scientific Committee of UFR des Sciences de la Santé (Teaching and research unit of medical and biological sciences) – Versailles St-Quentin University

Member of the medical HDR commission of Paris-Saclay university

Assistant Scientific director of Graduates school Life Sciences Health, Paris Saclay University

Major founding

• 2017 Subvention DIM1HEALTH (Region Ile de France) ; Project « ELUCIDER LES MECANISMES DU TRANSPORT INTRACELLULAIRE DU RSV »
• 2018 ATIP AVENIR INSERM Project: “From virus factories to the export of new virions: unravelling the mystery of the respiratory syncytial virus replication”
• 2020-2022 Subvention from fondation Simone and Cino Del Duca, Institut de France. Project “Deciphering the mechanisms of respiratory syncytial virus replication from viral factories to the export of new virions “.
• 2020 – 2021 Special call for projects from Versailles St-Quentin university. ” SEROCOV : Développement d’un test sérologique pour le SARS-CoV2 “.
• 2021-2025: ANR project: RSVFact “Towards the elucidation of the morphogenesis, organization and functioning of respiratory syncytial virus factories”. 3 partners : Galloux, Unité de Virologie et Immunologie Moléculaires, INRAe, Jouy-en-Josas ; Z. Gueroui DR2 CNRS, UMR8640-Ecole Normale Supérieure, Paris and my team.
• 2022-2023: Extension of ATIP-AVENIR Funding for 2 years.